Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-018346
Filing Date
2024-06-27
Accepted
2024-06-27 17:01:54
Documents
2
Period of Report
2024-06-25

Document Format Files

Seq Description Document Type Size
1 form4-06272024_090651.html 4  
1 form4-06272024_090651.xml 4 4069
2 ex24-06272024_090652.htm EX-24 4786
  Complete submission text file 0001415889-24-018346.txt   10349
Mailing Address 221 W PHILADELPHIA ST SUITE 60W YORK PA 17401-2991
Business Address
CHOLMONDELEY PAULA H (Reporting) CIK: 0001193675 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41855 | Film No.: 241080143

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)